Eli Lilly & Company announces a $5.3 billion expansion in Indiana for increased production of Zepbound and Mounjaro drugs.
Eli Lilly & Company announced a $5.3 billion expansion of its manufacturing facility in Lebanon, Indiana, to boost production of its popular weight-loss and diabetes drugs, Zepbound and Mounjaro. This investment, which brings the total investment to $9 billion, is the largest in the company's nearly 150-year history. The new production will help address the current shortage of the drugs due to soaring demand.
May 24, 2024
25 Articles